Chronic lymphocytic leukaemia presenting with central nervous system involvement

Medical Oncology

Volumn 16, Issue 1, 1999, Pages 65-68

  Poplawska Szczyglowska, Lidia ^a   Walewski, Jan ^a   Pienkowska Grela, Barbara ^a   Rymkiewicz, Grzegorz ^a   Mioduszewska, Olga ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

B cell chronic lymphocytic leukaemia; Central nervous system involvement; FISH; Immunophenotype; Trisomy 12

Indexed keywords

ANTIBIOTIC AGENT; CD20 ANTIGEN; CD23 ANTIGEN; DEXAMETHASONE; LOMUSTINE; METHOTREXATE; PROCARBAZINE;

AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; DISEASE COURSE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HEMIPARESIS; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTOSIS; MALE; MONONUCLEAR CELL; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; TRISOMY;

EID: 0033005687     PISSN: 07360118     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02787361     Document Type: Article

References (17)

1. Gahrton G et al. Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell-mitogen stimulation. Blood 1980; 56: 640-647.
2. Anastasi J et al. Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: A simple and sensitive method. Blood 1998; 79: 1796-1801.
3. Juliusson G, Merup M. Cytogenetics in chronic lymphocytic leukemia. Semin Oncol 1998; 25: 19-26.
4. Stilgenbauer S, Dohner K, Bentz M, Lichter P, Dohner H. Molecular cytogenetic analysis of B-cell chronic lymphocytic leukemia. Ann Hematol 1998; 76: 101-110.
5. O'Brien S, del Giglio A, Keating M. Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood 1995; 85: 307-318.
6. Juliusson G et al. Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytoma. Blood 1985; 65: 134-141.
7. Robert K-H et al. Extra chromosome 12 and prognosis in chronic lymphocytic leukemia. Scand J Haematol 1982; 28: 163-168.
8. Juliusson G. Immunological and cytogenetic studies improve prognosis prediction in chronic B-lymphocytic leukemia: A multivariate analysis of 24 variables. Cancer 1986; 58: 688-692.
9. Lane P, Townsend R, Beckstead J, Corash L. Central nervous system involvement in a patient with chronic lymphocytic leukemia and non-Hodgkin's lymphoma (Richter's syndrom), with concordant cell surface immunoglobulin isotypic and immunophenotypic markers. Am J Clin Pathol 1988; 89: 254-259.
10. O'Neill B, Habermann T, Banks P, O'Fallon J, Earle J. Primary central nervous system lymphoma as a variant of Richter's syndrome in two patients with chronic lymphocytic leukemia. Cancer 1989; 64: 1296-1300.
11. Bayliss K, Kueck B, Hanson C, Matthaeus W, Almagro U. Richter's syndrome presenting as primary central nervous system lymphoma. Transformation of an identical clone. Am J Clin Pathol 1990; 93: 117-123.
12. Majumdar G. Chronic lymphocytic leukaemia with cerebral infiltration. Leuk Lymphoma 1998; 28: 603-605.
13. Weizsaecker M, Kelmel H. Meningeal involvement in leukemias and malignant lymphomas of adults: incidence, course of disease, and treatment for prevention. Acta Neurol Scand 1979; 60: 363-370.
14. Cash J, Fehir K, Pollack M. Meningeal involvement in early stage chronic lymphocytic leukemia. Cancer 1987; 59: 656-659.
15. Finn W et al. Karyotypes correlates with peripheral blood morphology and immunophenotype in chronic lymphocytic leukemia. Am J Clin Pathol 1996; 105: 458-467.
16. Matutes E et al. Trisomy 12 defines a group of CLL with atypical morphology: Correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 1996; 92: 382-388.
17. Molica S, Dattil A, Levato D. Clinical relevance of the intensity of CD20 antigen in B-cell chronic lymphocytic leukemia. Blood 1996; 88(suppl): 239a.